Part 1 of 2
Billions of taxpayer dollars may have gone down the drain. Hundreds of thousands of patients may have been given useless medicine. Two decades of valuable time may have been wasted. It's quite sad.
It’s very possible that everything that we have been told about Alzheimer’s disease over the past 16 years has been a complete lie. A few weeks ago, a neuroscientist and professor named Matthew Schrag from Vanderbilt University alerted the scientific community that nearly two decades of Alzheimer’s research has very likely been based on fraud and deceit. He revealed that the authors of a groundbreaking 2006 paper on Alzheimer's may have manipulated key photographic evidence in their report in order to promote the theory that beta-amyloid plaques in the brain are the primary culprits of the disease. Sylvain Lesné and Karen Ashe, the two authors who have been implicated in this scandal, are both under investigation at the present time. If these explosive allegations are proven to be true, the implications will be absolutely devastating to the field of Alzheimer's research.
The uncovering of such shameless skulduggery would reverse almost two decades of Alzheimer's research over night. Such a revelation would mean that:
Basically all of the Alzheimer’s drugs that are currently on the market are placebos and scams.
It would mean that the research being done on the 100 beta-amyloid attacking Alzheimer’s drugs that are currently in clinical trials should be halted.
It would mean that patients who did suffer and die from what was labeled as Alzheimer’s may have been suffering from something else.
It would explain why other memory loss researchers have had problems replicating the results of the widely cited 2006 paper.
It would also explain why almost every major Alzheimer’s drug that has been produced since 2006 has seemingly had no effect on the disease. (99% failure rate)
In sum, it would be an immensely destabilizing blow to the integrity of American medical research.
Nonetheless, it’s far better to know the bitter truth about the state of Alzheimer’s research rather than continuing to be deceived by sweet lies.
While the beta-amyloid plaques probably do play a role in the genesis and the progression of Alzheimer’s disease, there are other complex factors that probably have a more direct impact on memory loss and dementia. However, research on those alternative causes has been stymied by the fact that the medical industry has placed undue emphasis and financial backing behind the beta amyloid hypothesis.
Comentarios